[opportunities] PATH | Request for Quotation #2023-010: HCV Treatment Medication | For circulation

[Hang Nguyen Thuc]

To whom it may concern,


PATH is looking for a vendor to provide pharmaceutical products with HCV treatment medication, namely Sofosbuvir 400mg and Daclatasvir 60mg (Daclatasvir dihydrochloride) to support the research study in Vietnam under the HIV Self-Testing Africa (STAR), a Unitaid-funded initiative. Through the HIV Self-Testing Africa consortium, PATH will conduct implementation research to assess different HCVST delivery models in two HIV Self-Testing Africa countries-India and Vietnam-which have high HCV disease burden and diagnostic gaps among KPs and PLHIV.



Quantity and detailed requirements of the needed products are listed in the attached Request for Quotation (RFQ) .



Deadline for quotation submission is 5:00PM (Hanoi time, GMT+7) on May 23, 2023
For submission of quotation and queries, please email to:
Finance/Administrative Contact: Mr. Tran Minh Dung. Email: dtran at path.org<mailto:dtran at path.org>
Technical/Program Contact: Mr. Do Tuan Kim. Email: kdo at path.org<mailto:kdo at path.org>
Procurement Associate Contact: Ms. Nguyen Thuc Hang. Email: htnguyen at path.org<mailto:htnguyen at path.org>

We would appreciate if you could circulate this RFQ to your network of contacts and to those who may be eligible and interested.

Thanks and best regards,

[cid:image001.png at 01D9898D.A4B4B2C0]

Nguyen Thuc Hang
Procurement Associate

Address: #1101, 11th Floor, Hanoi Towers, 49 Hai Ba Trung Street | Hanoi 10000 Vietnam
Tel: 84-24-3936 2215/Ext.175 | Fax: 84-24-3936 2216 | Mob: 84-862844184
path.org<http://www.path.org/>
Facebook<https://www.facebook.com/PATHglobalhealth/>  |  Twitter<https://twitter.com/PATHtweets/>  |  LinkedIn<https://www.linkedin.com/company/path/>

The information in this message, including any attachments, is intended only for the designated recipient(s), and may be privileged, confidential, or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, alteration, dissemination, retention, distribution, or use in any way of this message, its contents, and any attachments, is strictly prohibited. If you have received this message in error, please notify the sender immediately by reply e-mail and delete this message.

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://ngocentre.org.vn/pipermail/opportunities/attachments/20230518/a46eee3c/attachment.html 
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 5914 bytes
Desc: image001.png
Url : http://ngocentre.org.vn/pipermail/opportunities/attachments/20230518/a46eee3c/attachment.png 
-------------- next part --------------
A non-text attachment was scrubbed...
Name: REVISED RFQ 2023-010 HCV Treatment Medication - local.pdf
Type: application/pdf
Size: 82946 bytes
Desc: REVISED RFQ 2023-010 HCV Treatment Medication - local.pdf
Url : http://ngocentre.org.vn/pipermail/opportunities/attachments/20230518/a46eee3c/attachment.pdf